4Lukacs B,Leplege A,Thibault P,et al.Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners:1-year results[J].Urology,1996,48:731-740. 被引量：1
5Van Kcrrebroeck P.Long-term safety and efficacy of a oncedaily formulation of alfuzosin 10 mg in patients with symptomatic benign prostatic hyperplasia:open label extension study[J].Eur Urol,2002,41:54-60. 被引量：1
6Van Moorselaar RJ,Hartung R,Emberton M,et al.Alfuzo sin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction[J].BJU Int,2005,95:603-608. 被引量：1
8Lukacs B,Grange JC,Comet D,et al.Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in general practice[J].Prostate Cancer Prostatic Disease,1998,1:276-280. 被引量：1
9Lukacs B,Grange JC,McCarthy C,et al.Clinical uroselectivity:a 3-year follow-up in general practice.BPM Group in General Practice[J].Eur Urol,1998,33(Suppl):28-33. 被引量：1
10Jardin A,Vensadoum H,Delauche-Cavallier MC,et al.Alfuzosin for treatment of benign prostatic hypertrophy.The BPH-ALF Group[J].Lancet,1991,337:1457-1461. 被引量：1
2Kirby RS, Andersen M, Gratzke P, et al. A combined analysis of double-blind trial of the efficacy and tolerability of doxazocin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with BPH[J].BJU Int,2001, 87:192-200. 被引量：1
3Kirby RS. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with BPH[J].BJU Int, 2003, 91:41-44. 被引量：1
4Kypranou N, Lituak JP, Borkowski A, et al. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia[J].J Urol,1998, 159:1810-1815. 被引量：1
5Chon JK. Alphal-adrenoceptor antagonists doxazosin and terazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostate hyperplasia[J].J Urol,1999, 161: 2002-2008. 被引量：1
6Cal C, Uslu R, Gunaydim G, et al. Doxazosin: a new cytotoxic agent for prostate cancer[J].Br J Urol, 2000, 85:672-675. 被引量：1
7Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study: Final results[J].JAMA,1993, 270: 8-12. 被引量：1
8ALLHAT Collaborative Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial[J].JAMA,2000, 283: 1967-1975. 被引量：1
9Cho YH, Kim DG, Lee KS, Effects of doxazosin on sexual function in patients with benign prostatic hyperplasia[J].The Korean J Urol,2004 45(2): 130-134. 被引量：1
10Chapple CR. The total approach in low urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management: introduction and conclusion[J].Eur Urol,2003, 2: 1. 被引量：1
